Stuart Goldstein, MD
Pediatric Nephrology · Cincinnati, OHNPI 1780764035
Payments from drug & device makers
Across 386 payments — averaging $2325.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Baxter Healthcare$370K
- Medtronic$118K
- Genentech, Inc.$106K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$81K
- Nuwellis, Inc.$50K
- Vantive US Healthcare LLC$36K
- plus $138K from 21 others
Across 12 payments — averaging $1944.41 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$11K
- Covidien LP$9K
- Kaneka Medical America LLC$3K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Baxter Healthcare | 127 | $369,616 |
| Medtronic | 26 | $117,836 |
| Genentech, Inc. | 14 | $105,581 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 23 | $80,783 |
| Nuwellis, Inc. | 34 | $49,584 |
| Vantive US Healthcare LLC | 23 | $36,103 |
| Fresenius USA Marketing, Inc. | 66 | $30,719 |
| Octapharma USA, Inc. | 2 | $30,600 |
| Exthera Medical Corporation | 19 | $22,666 |
| Kaneka Medical America LLC | 2 | $10,268 |
| Mallinckrodt Hospital Products Inc. | 4 | $8,763 |
| Leadiant Biosciences, Inc. | 4 | $6,375 |
| AstraZeneca(2 entities) | 4 | $5,325 |
| Akebia Therapeutics Inc | 3 | $5,160 |
| Covidien LP | 14 | $4,713 |
| Bio Products Laboratory USA, Inc. | 3 | $4,500 |
| Mozarc Medical US LLC | 5 | $3,886 |
| E.r. Squibb & Sons, L.L.C. | 1 | $1,330 |
| Potrero Medical, Inc. | 2 | $1,309 |
| Astellas Pharma Inc | 1 | $850 |
| Acelrx Pharmaceuticals, Inc. | 1 | $700 |
| La Jolla Pharmaceutical Company | 1 | $525 |
| Amgen(2 entities) | 2 | $160 |
| Biomerieux Inc | 1 | $144 |
| Novartis | 2 | $133 |
| Dexcom, Inc. | 1 | $109 |
| Outset Medical Inc | 1 | $12 |
How this compares
$897,749 in reported general payments places this provider in the 95th percentile of 44 pediatric nephrology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pediatric nephrology in Cincinnati
- Francisco FloresCincinnati$256K
- Prasad DevarajanCincinnati$162K
- Meredith SchuhCincinnati$117K
- Stefanie BenoitCincinnati$52K
- Meredith HarrisCincinnati$7K
- Hillarey StoneCincinnati$5K
- Jean-Philippe RoyCincinnati$1K
- Elif ErkanCincinnati$1K
- Charles VarnellCincinnati$159
- Kyle McCrackenCincinnati$146
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.